{
  "id": 6838855,
  "title": "IXJ vs XPH: Global Healthcare ETF or Pharma Focus?",
  "url": "https://urgent.news/2026/09/12/ixj-vs-xph-global-healthcare-etf-or-pharma-focus",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-12T01:29:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/09/11/ixj-vs-xph-global-healthcare-etf-or-pharma-focus/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "IXJ vs XPH: Global Healthcare ETF or Pharma Focus?",
        "url": "https://urgent.news/2026/09/12/ixj-vs-xph-global-healthcare-etf-or-pharma-focus-6840058",
        "published": "2026-09-12T01:49:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}